Joint (JYNT) Receives a Buy from B.Riley FBR

By Ryan Adsit

B.Riley FBR analyst Jeff Van Sinderen reiterated a Buy rating on Joint (JYNTResearch Report) today and set a price target of $23.00. The company’s shares closed last Monday at $20.04, close to its 52-week high of $21.80.

According to TipRanks.com, Sinderen is a 1-star analyst with an average return of -2.1% and a 46.1% success rate. Sinderen covers the Consumer Goods sector, focusing on stocks such as Universal Electronics, Celsius Holdings, and Chromadex.

Currently, the analyst consensus on Joint is a Strong Buy with an average price target of $26.00.

See today’s analyst top recommended stocks >>

The company has a one-year high of $21.80 and a one-year low of $6.51. Currently, Joint has an average volume of 133.1K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

The Joint Corp. (United States) engages in the development, ownership, operation, support and management of chiropractic clinics. It operates through two segments: Corporate Clinics and Franchise Operations. The Corporate Clinics segment comprises of the operating activities of the company owned or managed clinics.